Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]. | Z Rheumatol | 2023 | 36342525 | PubTator, text mining | PubMed |
| Proteolytic cleavage of membrane proteins by membrane type-1 MMP regulates cancer malignant progression. | Cancer Sci | 2023 | 36336966 | PubTator, text mining | PubMed |
| The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis. | Cell Mol Gastroenterol Hepatol | 2023 | 36309199 | PubTator, text mining | PubMed |
| Aerosol physicochemical determinants of carbon black and ozone inhalation co-exposure induced pulmonary toxicity. | Toxicol Sci | 2023 | 36303316 | PubTator, text mining | PubMed |
| Emerging frontiers in immuno- and gene therapy for cancer. | Cytotherapy | 2023 | 36280438 | PubTator, text mining | PubMed |
| Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. | Neuro Oncol | 2023 | 36239313 | PubTator, text mining | PubMed |
| The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities. | Neurosci Bull | 2023 | 36229714 | PubTator, text mining | PubMed |
| Cellular immunotherapy for medulloblastoma. | Neuro Oncol | 2023 | 36219688 | PubTator, text mining | PubMed |
| Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis. | Allergy | 2023 | 36070083 | PubTator, text mining | PubMed |
| Preterm labor with and without chorioamnionitis is associated with activation of myometrial inflammatory networks: a comprehensive transcriptomic analysis. | Am J Obstet Gynecol | 2023 | 36002050 | PubTator, text mining | PubMed |
| Biologics in eosinophilic gastrointestinal diseases. | Ann Allergy Asthma Immunol | 2023 | 35738437 | PubTator, text mining | PubMed |
| Improving hard metal implant and soft tissue integration by modulating the "inflammatory-fibrous complex" response. | Bioact Mater | 2023 | 35633873 | PubTator, text mining | PubMed |
| IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis. | Gut | 2023 | 35613844 | PubTator, text mining | PubMed |
| Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. | Cell Biol Toxicol | 2023 | 35412187 | PubTator, text mining | PubMed |
| Current Concepts on the Pathogenesis of Systemic Sclerosis. | Clin Rev Allergy Immunol | 2023 | 34487318 | PubTator, text mining | PubMed |
| Recent advances in overcoming barriers to cell-based delivery systems for cancer immunotherapy. | Exploration (Beijing) | 2022 | 37323702 | PubTator, text mining | PubMed |
| Innate lymphoid cells in depression: Current status and perspectives. | Biomark Neuropsychiatry | 2022 | 37123464 | PubTator, text mining | PubMed |
| Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Based Chemotherapy. | Pancreas | 2022 | 37078936 | PubTator, text mining | PubMed |
| Molecular pathology and clinical implications of diffuse glioma. | Chin Med J (Engl) | 2022 | 36728558 | PubTator, text mining | PubMed |
| A potential three-gene-based diagnostic signature for idiopathic pulmonary fibrosis. | Front Genet | 2022 | 36685820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=28